ANTIPLATELET ACTIVITIES OF FK409, A NEW SPONTANEOUS NO RELEASER

被引:24
作者
KITA, Y
HIRASAWA, Y
YOSHIDA, K
MAEDA, K
机构
[1] Department of Pharmacology, New Drug Research Laboratories, Fujisawa Pharmaceutical Co, Ltd., Osaka, 532, 1‐6, 2‐chome, Kashima Yodogawa‐ku
关键词
FK409; ISOSORBIDE DINITRATE; NITRIC OXIDE; ANTIPLATELET ACTIVITY;
D O I
10.1111/j.1476-5381.1994.tb17000.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 We reported that (+/-)-(E)-ethyl-2-[(E)-hydroxyimino]-5-nitro (FK409) released nitric oxide (NO) spontaneously with a chemiluminescence analyzer. The aim of this study was to compare antiplatelet activities of FK409, a new NO releaser, with those of isosorbide dinitrate (ISDN) in vivo and in vitro. In order to elucidate the differences in antiplatelet activities between FK409 and ISDN, we compared their modes of action. 2 In in vitro experiments, FK409 had a more potent inhibitory effect on rat platelet aggregation induced by adenosine 5'-diphosphate (2.0 mu M) than ISDN (IC50 = 4.32 +/- 0.95 mu M and > 100 mu M respectively). 3 In the rat extracorporeal shunt model (in vivo experiments), FK409 suppressed thrombus formation dose-dependently from 0.32 mg kg(-1), p.o. and showed the maximum inhibition (52% inhibition vs. vehicle treatment) at 10 mg kg(-1), p.o., while ISDN showed no inhibition at 10 mg kg(-1) and only 17% inhibition at 32 mg kg(-1), p.o. 4 FK409 could generate nitrite, which is an oxidative product of NO, much faster than ISDN in phosphate buffer solution and rat plasma during 60-min incubation at 37 degrees C. 5 These data show that FK409 has more potent antiplatelet effects than ISDN, by acting through spontaneously released NO.
引用
收藏
页码:385 / 388
页数:4
相关论文
共 20 条
[1]   DETERMINATION OF OIL/WATER DISTRIBUTION COEFFICIENTS OF GLYCERYL TRINITRATE AND 2 SIMILAR NITRATE ESTERS [J].
BELL, FK ;
BURGISON, RM ;
ONEILL, JJ .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1963, 52 (07) :637-&
[2]  
BORN GV, 1968, J PHYSL, V168, P178
[3]  
CHONG S, 1990, DRUG METAB DISPOS, V18, P61
[4]  
DECATERINA R, 1984, AM J CARDIOL, V53, P1683
[5]   NITRIC-OXIDE (NO) FORMATION FROM NITROVASODILATORS OCCURS INDEPENDENTLY OF HEMOGLOBIN OR NONHEME IRON [J].
FEELISCH, M ;
NOACK, E .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1987, 142 (03) :465-469
[6]   CORRELATION BETWEEN NITRIC-OXIDE FORMATION DURING DEGRADATION OF ORGANIC NITRATES AND ACTIVATION OF GUANYLATE-CYCLASE [J].
FEELISCH, M ;
NOACK, EA .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1987, 139 (01) :19-30
[7]   INSIGHTS INTO THE PATHOGENESIS OF ACUTE ISCHEMIC SYNDROMES [J].
FUSTER, V ;
BADIMON, L ;
COHEN, M ;
AMBROSE, JA ;
BADIMON, JJ ;
CHESEBRO, J .
CIRCULATION, 1988, 77 (06) :1213-1220
[8]  
HAMPTON J. R., 1967, CARDIOVASC RES, V1, P101, DOI 10.1093/cvr/1.2.101
[9]   FK409, A NOVEL VASODILATOR ISOLATED FROM THE ACID-TREATED FERMENTATION BROTH OF STREPTOMYCES-GRISEOSPOREUS .1. TAXONOMY, FERMENTATION, ISOLATION, AND PHYSICOCHEMICAL AND BIOLOGICAL CHARACTERISTICS [J].
HINO, M ;
IWAMI, M ;
OKAMOTO, M ;
YOSHIDA, K ;
HARUTA, H ;
OKUHARA, M ;
HOSODA, J ;
KOHSAKA, M ;
AOKI, H ;
IMANAKA, H .
JOURNAL OF ANTIBIOTICS, 1989, 42 (11) :1578-1583
[10]   ROLE OF ANTITHROMBOTIC THERAPY IN UNSTABLE ANGINA, MYOCARDIAL-INFARCTION AND SUDDEN-DEATH [J].
HJEMDAHLMONSEN, CE ;
LEWIS, HD ;
CAIRNS, J ;
CHESEBRO, JH ;
FUSTER, V .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1986, 8 (06) :B67-B75